Principal Healthcare Innovators ETF (BTEC) Research
The fund typically allocates at least 80% of its overall assets, augmented by any borrowed capital used for investment, to equity holdings of companies within the healthcare industry. A considerable portion of its capital is directed towards innovative, early-stage businesses in areas such as medical equipment and supplies, pharmaceuticals, biotechnology, and the broader life sciences, many of which have not yet achieved consistent profitability.
Market snapshot
- Symbol
- BTEC
- Price
- $39.49
- Day change
- +1.02%
- Market cap
- $16.2M
- 52-week range
- 25.66-41.1
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- iPath Pure Beta Broad Commodity ETN (BCM)
- Xtrackers Japan JPX-Nikkei 400 Equity ETF (JPN)
- VanEck Morningstar ESG Moat ETF (MOTE)
- QUANTX Risk Managed Multi-Asset Total Return ETF (QXTR)
- First Trust Mid Cap US Equity Select ETF (RNMC)
- Defiance Next Gen SPAC Derived ETF (SPAK)
- SPDR MFS Systematic Growth Equity ETF (SYG)
- Syntax Stratified U.S. Total Market ETF (SYUS)
Open Principal Healthcare Innovators ETF (BTEC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.